+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Xopenex"

Xopenex - API Insight, 2022 - Product Thumbnail Image

Xopenex - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Xopenex- Drug Insight, 2019 - Product Thumbnail Image

Xopenex- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
From
  • 7 Results (Page 1 of 1)
Loading Indicator

Xopenex (levosalbutamol) is a prescription medication used to treat and prevent symptoms of airway diseases, such as asthma and chronic obstructive pulmonary disease (COPD). It is a bronchodilator, meaning it works by relaxing the muscles in the airways, allowing more air to flow in and out of the lungs. Xopenex is a brand name for levalbuterol, a short-acting beta-2 agonist (SABA). It is available in both an inhalation solution and an inhalation aerosol. Xopenex is used to treat and prevent symptoms of airway diseases, such as wheezing, chest tightness, and shortness of breath. It is also used to prevent exercise-induced bronchospasm. Xopenex is typically used in combination with other medications, such as inhaled corticosteroids, to treat and prevent symptoms of airway diseases. The Xopenex market is a subset of the larger respiratory drugs market. It is composed of companies that manufacture and distribute Xopenex and related products. These companies include Sunovion Pharmaceuticals, Teva Pharmaceuticals, Mylan Pharmaceuticals, and Hikma Pharmaceuticals. Show Less Read more